Other Projects

ESTEVE has several new molecular entities projects for unmet needs in different stages of development with the aim to obtain treatments with better benefit-risk than the current treatments.

Some of these projects (Multimodal 2, Multimodal 3, Multimodal 5 and Sigma-1 new indications) have been supported by the Spanish Ministry of Economy, Industry and Competitiveness through the Centre for the Development of Industrial Technology (CDTI) and have been co-financed by the European Union through the European Regional Development Fund (ERDF).

 

This Website uses its own and third-party cookies to improve our services and analyse the user's browsing habits. If you continue browsing, we will consider you to have accepted their use. You can find more information by visiting our Cookies policy.